腫瘍栄養学市場- 世界の産業規模、シェア、動向、機会および予測、がんタイプ別、栄養剤別、流通チャネル別、エンドユーザー別、地域別、競合市場別、2020-2030年

世界の腫瘍栄養学市場は、2024年に25億3,000万米ドルの規模に達し、2030年には41億米ドルに達すると予測され、予測期間中のCAGRは8.35%で成長します。

この市場は、世界のがん罹患率の増加、がん治療計画における重要な要素としての栄養の臨床的認知の高まり、患者中心の全人的ケア提供への移行などを背景に、ダイナミックな拡大を続けています。かつては補助的な診療と見なされていた腫瘍栄養学は、現在では集学的治療アプローチにおいて不可欠な役割を果たしています。この進化は、疾患特異的製剤の使用の増加、ケアパスにおける栄養の制度的標準化、および患者固有の代謝ニーズによって導かれる精密栄養によって推進されています。栄養供給およびリアルタイムの健康モニタリングにおける技術革新は、より効果的な介入を可能にし、製品開発を進めています。栄養サポートと治療結果の改善との関連性がより実証されるにつれて、市場は一般的な栄養サポートからエビデンスに基づく治療ソリューションへと移行しつつあります。このため、がん患者の臨床転帰の改善、コスト効率の向上、QOLの向上を目指す既存企業や新興の革新的企業にとって、大きな成長の可能性が生まれています。

市場促進要因

世界のがん罹患率および死亡率の急上昇

主な市場課題

規制の複雑さ

主要市場動向

ニュートリゲノミクスの台頭

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 腫瘍栄養学市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • がんの種類別（肺がん、頭頸部がん、胃・消化器がん、食道がん、肝がん、血液がん、その他）
  • 栄養（経腸栄養、静脈栄養）
  • 式別（標準式、元素式、特殊式）
  • 流通チャネル別（病院薬局、オンライン薬局、小売薬局）
  • エンドユーザー別（病院、在宅ケア、専門クリニック）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の腫瘍栄養学市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の腫瘍栄養学市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の腫瘍栄養学市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の腫瘍栄養学市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの腫瘍栄養学市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の腫瘍栄養学市場：SWOT分析

第14章 競合情勢

• Abbott Laboratories Inc
• Nestle SA
• Fresenius Kabi AG
• B Braun SE
• Hormel Foods Corporation
• Danone SA
• MEIJI Holdings Co Ltd
• Global Health Products, Inc.
• Victus Inc
• Mead Johnson & Co LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Oncology Nutrition Market reached a value of USD 2.53 billion in 2024 and is projected to attain USD 4.10 billion by 2030, growing at a CAGR of 8.35% during the forecast period. This market is undergoing dynamic expansion fueled by the increasing global cancer burden, the heightened clinical recognition of nutrition as a key component in oncology treatment plans, and the transition toward holistic, patient-focused care delivery. Once seen as a supplementary practice, oncology nutrition now plays an essential role in multidisciplinary treatment approaches. This evolution is being propelled by the increased use of disease-specific formulations, institutional standardization of nutrition in care pathways, and precision nutrition guided by patient-specific metabolic needs. Technological innovations in nutrient delivery and real-time health monitoring are enabling more effective interventions and advancing product development. As the link between nutritional support and better treatment outcomes becomes more substantiated, the market is shifting from general nutritional support to evidence-based, therapeutic solutions. This creates substantial growth potential for established players and emerging innovators seeking to deliver enhanced clinical outcomes, cost efficiency, and improved quality of life for cancer patients.

Key Market Drivers

Surging Global Cancer Incidence and Mortality

The increasing global incidence and mortality rates associated with cancer are primary growth drivers for the oncology nutrition market. In 2022, around 20 million new cancer cases and 9.7 million cancer-related deaths were reported, emphasizing the urgent need for supportive care solutions. Approximately 53.5 million individuals were living within five years of a cancer diagnosis, reflecting both improved survival and growing disease prevalence. Lifestyle-related risk factors-such as poor diet, sedentary habits, smoking, and alcohol consumption-as well as aging populations, continue to elevate cancer incidence, particularly in developed regions. Individuals aged 60-69 are four times more likely to be diagnosed with cancer than those under 50, while those over 70 face a tenfold increase in risk. The rising number of cancer diagnoses is directly increasing demand for comprehensive treatment support, including specialized nutritional interventions that can aid in managing side effects, boosting recovery, and enhancing treatment adherence.

Key Market Challenges

Regulatory Complexity

The oncology nutrition sector faces regulatory hurdles due to diverse and complex standards governing product development, labeling, and distribution across regions. Regulations vary significantly by country, and navigating this fragmented regulatory landscape is time-consuming and resource-intensive. Global companies must invest heavily in compliance to meet these evolving regulatory requirements, which can slow innovation and market expansion.

Key Market Trends

Rise of Nutrigenomics

Nutrigenomics-the study of how an individual's genetic makeup influences their response to nutrients-is gaining momentum in oncology nutrition. This approach enables highly personalized dietary plans that align with a patient's unique genetic and metabolic profile. It has the potential to revolutionize cancer care by improving treatment effectiveness, minimizing side effects, and enhancing overall outcomes through customized nutritional strategies rooted in precision medicine.

Key Market Players

• Abbott Laboratories Inc
• Nestle SA
• Fresenius Kabi AG
• B Braun SE
• Hormel Foods Corporation
• Danone SA
• MEIJI Holdings Co Ltd
• Global Health Products, Inc.
• Victus Inc
• Mead Johnson & Co LLC

Report Scope:

In this report, the Global Oncology Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Nutrition Market, By Cancer Type:

• Lung Cancer
• Head and Neck Cancer
• Stomach and Gastrointestinal Cancers
• Esophageal Cancer
• Liver Cancer
• Blood Cancer
• Others

Oncology Nutrition Market, By Nutrition:

• Enteral Nutrition
• Parenteral Nutrition

Oncology Nutrition Market, By Formula:

• Standard Formula
• Elemental Formula
• Specialized Formula

Oncology Nutrition Market, By Distribution Channel:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Oncology Nutrition Market, By End User:

• Hospitals
• Homecare
• Specialty Clinics

Oncology Nutrition Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oncology Nutrition Market.

Available Customizations:

Global Oncology Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Oncology Nutrition Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
  • 5.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
  • 5.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
  • 5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
  • 5.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Oncology Nutrition Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Cancer Type
  • 6.2.2. By Nutrition
  • 6.2.3. By Formula
  • 6.2.4. By Distribution Channel
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oncology Nutrition Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Cancer Type
      • 6.3.1.2.2. By Nutrition
      • 6.3.1.2.3. By Formula
      • 6.3.1.2.4. By Distribution Channel
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Oncology Nutrition Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Cancer Type
      • 6.3.2.2.2. By Nutrition
      • 6.3.2.2.3. By Formula
      • 6.3.2.2.4. By Distribution Channel
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Oncology Nutrition Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Cancer Type
      • 6.3.3.2.2. By Nutrition
      • 6.3.3.2.3. By Formula
      • 6.3.3.2.4. By Distribution Channel
      • 6.3.3.2.5. By End User

7. Europe Oncology Nutrition Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Cancer Type
  • 7.2.2. By Nutrition
  • 7.2.3. By Formula
  • 7.2.4. By Distribution Channel
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oncology Nutrition Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Cancer Type
      • 7.3.1.2.2. By Nutrition
      • 7.3.1.2.3. By Formula
      • 7.3.1.2.4. By Distribution Channel
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Oncology Nutrition Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Cancer Type
      • 7.3.2.2.2. By Nutrition
      • 7.3.2.2.3. By Formula
      • 7.3.2.2.4. By Distribution Channel
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Oncology Nutrition Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Cancer Type
      • 7.3.3.2.2. By Nutrition
      • 7.3.3.2.3. By Formula
      • 7.3.3.2.4. By Distribution Channel
      • 7.3.3.2.5. By End User
  • 7.3.4. France Oncology Nutrition Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Cancer Type
      • 7.3.4.2.2. By Nutrition
      • 7.3.4.2.3. By Formula
      • 7.3.4.2.4. By Distribution Channel
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Oncology Nutrition Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Cancer Type
      • 7.3.5.2.2. By Nutrition
      • 7.3.5.2.3. By Formula
      • 7.3.5.2.4. By Distribution Channel
      • 7.3.5.2.5. By End User

8. Asia-Pacific Oncology Nutrition Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Cancer Type
  • 8.2.2. By Nutrition
  • 8.2.3. By Formula
  • 8.2.4. By Distribution Channel
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Oncology Nutrition Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Cancer Type
      • 8.3.1.2.2. By Nutrition
      • 8.3.1.2.3. By Formula
      • 8.3.1.2.4. By Distribution Channel
      • 8.3.1.2.5. By End User
  • 8.3.2. India Oncology Nutrition Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Cancer Type
      • 8.3.2.2.2. By Nutrition
      • 8.3.2.2.3. By Formula
      • 8.3.2.2.4. By Distribution Channel
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Oncology Nutrition Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Cancer Type
      • 8.3.3.2.2. By Nutrition
      • 8.3.3.2.3. By Formula
      • 8.3.3.2.4. By Distribution Channel
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Oncology Nutrition Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Cancer Type
      • 8.3.4.2.2. By Nutrition
      • 8.3.4.2.3. By Formula
      • 8.3.4.2.4. By Distribution Channel
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Oncology Nutrition Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Cancer Type
      • 8.3.5.2.2. By Nutrition
      • 8.3.5.2.3. By Formula
      • 8.3.5.2.4. By Distribution Channel
      • 8.3.5.2.5. By End User

9. South America Oncology Nutrition Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Cancer Type
  • 9.2.2. By Nutrition
  • 9.2.3. By Formula
  • 9.2.4. By Distribution Channel
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Oncology Nutrition Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Therapy
  • 9.3.2. Argentina Oncology Nutrition Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Cancer Type
      • 9.3.2.2.2. By Nutrition
      • 9.3.2.2.3. By Formula
      • 9.3.2.2.4. By Distribution Channel
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Oncology Nutrition Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Cancer Type
      • 9.3.3.2.2. By Nutrition
      • 9.3.3.2.3. By Formula
      • 9.3.3.2.4. By Distribution Channel
      • 9.3.3.2.5. By End User

10. Middle East and Africa Oncology Nutrition Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Cancer Type
  • 10.2.2. By Nutrition
  • 10.2.3. By Formula
  • 10.2.4. By Distribution Channel
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Oncology Nutrition Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Cancer Type
      • 10.3.1.2.2. By Nutrition
      • 10.3.1.2.3. By Formula
      • 10.3.1.2.4. By Distribution Channel
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Oncology Nutrition Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Cancer Type
      • 10.3.2.2.2. By Nutrition
      • 10.3.2.2.3. By Formula
      • 10.3.2.2.4. By Distribution Channel
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Oncology Nutrition Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Cancer Type
      • 10.3.3.2.2. By Nutrition
      • 10.3.3.2.3. By Formula
      • 10.3.3.2.4. By Distribution Channel
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Oncology Nutrition Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Nestle SA
• 14.3. Fresenius Kabi AG
• 14.4. B Braun SE
• 14.5. Hormel Foods Corporation
• 14.6. Danone SA
• 14.7. MEIJI Holdings Co Ltd
• 14.8. Global Health Products, Inc.
• 14.9. Victus Inc
• 14.10.Mead Johnson & Co LLC

15. Strategic Recommendations

16. About Us & Disclaimer